Half Yearly Results of Glenmark Pharma (in Rs. Cr.) |
Mar '20 |
Sep '19 |
Mar '19 |
Sep '18 |
Mar '18 |
|
Net Sales/Income from operations |
3,424.02 |
3,197.86 |
3,130.66 |
3,000.48 |
2,965.57 |
|
Other Operating Income |
-- |
90.76 |
88.66 |
85.07 |
258.72 |
|
Total Income From Operations |
3,424.02 |
3,288.61 |
3,219.32 |
3,085.55 |
3,224.29 |
|
EXPENDITURE |
|
|
|
|
|
|
Consumption of Raw Materials |
1,165.02 |
1,086.96 |
791.44 |
794.42 |
1,053.72 |
|
Purchase of Traded Goods |
175.76 |
189.49 |
138.51 |
162.79 |
152.46 |
|
Increase/Decrease in Stocks |
38.37 |
10.40 |
314.40 |
157.41 |
4.28 |
|
Power & Fuel |
-- |
-- |
-- |
-- |
-- |
|
Employees Cost |
506.52 |
565.81 |
456.31 |
513.67 |
487.73 |
|
Depreciation |
73.05 |
65.49 |
52.05 |
54.23 |
59.37 |
|
Excise Duty |
-- |
-- |
-- |
-- |
-- |
|
Admin. And Selling Expenses |
-- |
-- |
-- |
-- |
-- |
|
R & D Expenses |
-- |
-- |
-- |
-- |
-- |
|
Provisions And Contingencies |
-- |
-- |
-- |
-- |
-- |
|
Exp. Capitalised |
-- |
-- |
-- |
-- |
-- |
|
Other Expenses |
923.30 |
746.78 |
900.55 |
747.90 |
928.99 |
|
P/L Before Other |
542.01 |
623.69 |
566.05 |
655.15 |
537.74 |
|
Other Income |
345.78 |
261.01 |
83.75 |
391.87 |
81.53 |
|
P/L Before Int. |
887.79 |
884.69 |
649.80 |
1,047.01 |
619.27 |
|
Interest |
123.15 |
133.24 |
107.79 |
116.02 |
97.72 |
|
P/L Before Exceptional Items & Tax |
764.64 |
751.45 |
542.01 |
930.99 |
521.55 |
|
Exceptional Items |
18.55 |
-- |
-- |
345.19 |
-- |
|
P/L Before Tax |
783.19 |
751.45 |
542.01 |
1,276.17 |
521.55 |
|
Tax |
88.48 |
91.62 |
91.30 |
238.58 |
105.92 |
|
P/L After Tax from Ordinary Activities |
694.71 |
659.84 |
450.71 |
1,037.59 |
415.63 |
|
Prior Year Adjustments |
-- |
-- |
-- |
-- |
-- |
|
Extra Ordinary Items |
-- |
-- |
26.45 |
107.36 |
-- |
|
Net Profit/(Loss) For the Period |
694.71 |
659.84 |
477.16 |
1,144.95 |
415.63 |
|
Equity Share Capital |
28.22 |
28.22 |
28.22 |
28.22 |
28.22 |
|
Reserves Excluding Revaluation Reserves |
-- |
-- |
-- |
-- |
-- |
|
Equity Dividend Rate (%) |
-- |
-- |
-- |
-- |
-- |
|
EPS Before Extra Ordinary |
|
|
|
|
|
|
Basic EPS |
24.62 |
23.38 |
-- |
40.58 |
-- |
|
Diluted EPS |
-- |
23.38 |
-- |
40.58 |
-- |
|
EPS After Extra Ordinary |
|
|
|
|
|
|
Basic EPS. |
24.62 |
23.38 |
-- |
40.58 |
-- |
|
Diluted EPS. |
-- |
23.38 |
-- |
40.58 |
-- |
|
Public Share Holding |
|
|
|
|
|
|
No Of Shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
Share Holding (%) |
-- |
-- |
-- |
-- |
-- |
|
Promoters and Promoter Group Shareholding |
|
|
|
|
|
|
a) Pledged/Encumbered |
|
|
|
|
|
|
- Number of shares (Crores) |
-- |
-- |
-- |
-- |
-- |
|
- Per. of shares (as a % of the total sh. of prom. and promoter group) |
-- |
-- |
-- |
-- |
-- |
|
- Per. of shares (as a % of the total Share Cap. of the company) |
-- |
-- |
-- |
-- |
-- |
|
b) Non-encumbered |
|
|
|
|
|
|
- Number of shares (Crores). |
-- |
-- |
-- |
-- |
-- |
|
- Per. of shares (as a % of the total sh. of prom. and promoter group). |
-- |
-- |
-- |
-- |
-- |
|
- Per. of shares (as a % of the total Share Cap. of the company). |
-- |
-- |
-- |
-- |
-- |
|
Source : Dion Global Solutions Limited